Correspondence 0001493152-24-035645 from Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc.
Date: Sept. 10, 2024 · CIK: 0000890821 · Accession: 0001493152-24-035645
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281934
Letter
RE: Enveric Biosciences, Inc.
September 10, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N. E.
Washington, D. C. 20549
Registration Statement on Form S-1
(File No. 333-281934)
Acceleration Request
Requested Date: September 11, 2024
Requested Time: 4:30 p.m., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Enveric Biosciences, Inc. (the “Company”) requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Commission.
Please call Bradley J. Wyatt of Dickinson Wright PLLC at (734) 623-1905 to confirm the effectiveness of the Registration Statement or with any questions.
Very
truly yours,
Enveric
Biosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
September
10, 2024
VIA
EDGAR
United
States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N. E.
Washington, D. C. 20549
RE:
Enveric
Biosciences, Inc.
Registration
Statement on Form S-1
(File
No. 333-281934)
Acceleration
Request
Requested
Date: September 11, 2024
Requested
Time: 4:30 p.m., Eastern Time
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Enveric Biosciences, Inc. (the “Company”)
requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities
and Exchange Commission (the “Commission”) at the “Requested Date” and “Requested Time” set forth
above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation
Finance of the Commission.
Please
call Bradley J. Wyatt of Dickinson Wright PLLC at (734) 623-1905 to confirm the effectiveness of the Registration Statement or with any
questions.
Very
truly yours,
Enveric
Biosciences, Inc.
By:
/s/
Joseph Tucker
Name:
Joseph
Tucker, Ph.D.
Title:
Chief
Executive Officer